Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
Published on: May 24, 2024
The Prevalence, Mechanisms, and Clinical Significance of Inferior Vena Cava Compression in Autosomal Dominant
Ahmad Matarneh1, Bayan Matarneh2, Abdelrauof Akkari1
1Division of Nephrology, Department of Medicine, Penn State Health, Milton S. Hershey Medical Center, Hershey, PA 17033, USA.
Insights
Inferior vena cava (IVC) compression in autosomal dominant polycystic kidney disease (ADPKD) significantly worsens patient outcomes. This complication increases the risk of end-stage renal disease (ESRD), raises mortality rates, and reduces overall survival.
Area of Science:
- Nephrology
- Vascular Medicine
- Genetics
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is a primary cause of end-stage renal disease (ESRD).
- Progressive renal cyst growth in ADPKD can lead to mass effects, including inferior vena cava (IVC) compression.
- IVC compression is a rare but significant complication impacting hemodynamic stability and renal outcomes.
Purpose of the Study:
- To evaluate the prevalence of IVC compression in ADPKD patients.
- To assess the impact of IVC compression on progression to ESRD, mortality, and overall survival.
- To provide quantitative measures of the prognostic significance of IVC compression in ADPKD.
Main Methods:
- Retrospective cohort study using the TriNetX database.
- Inclusion of 658 ADPKD patients with IVC compression, compared to controls without compression.
- Analysis of outcomes including ESRD incidence, mortality, and survival using Kaplan-Meier curves and hazard ratios (HRs).
Main Results:
- IVC compression was associated with a 2.61-fold increased risk of ESRD (77.4% vs. 29.7%).
- Five-year survival was significantly reduced in patients with IVC compression (42.6% vs. 61.7%), with a hazard ratio of 4.00.
- Mortality was higher in the compression group (29.2% vs. 9.1%), and ESRD patients with IVC compression had a 5.60-fold higher mortality risk.
Conclusions:
- IVC compression in ADPKD is linked to substantially worse clinical outcomes.
- Early diagnosis and targeted management of IVC compression are crucial for improving patient prognosis.
- Findings highlight the prognostic importance of IVC compression in ADPKD progression and survival.
Abstract:
Background and Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is a leading cause of end-stage renal disease (ESRD). Progressive renal cyst growth in ADPKD can exert mass effects, including compression of the inferior vena cava (IVC), a rare but clinically significant complication with implications for hemodynamic stability and renal outcomes. This study evaluated the prevalence of IVC compression in ADPKD and its impact on progression to ESRD, mortality, and overall survival. We aimed to provide quantitative measures to elucidate its prognostic significance. Materials and Methods: Using the TriNetX database, we conducted a retrospective cohort study of 658 ADPKD patients with IVC compression, comparing them to unmatched controls without compression. Outcomes included ESRD incidence, mortality, and survival. Kaplan-Meier curves and hazard ratios (HRs) with 95% confidence intervals (CIs) were used for analysis. Results: ESRD Risk: IVC compression was associated with a higher risk of ESRD (77.4% vs. 29.7%, RR: 2.61, 95% CI: 2.49-2.73, p < 0.001). Survival Probability: 5-year Survival was significantly reduced in patients with IVC compression (42.6%) compared to controls (61.7%) (HR: 4.00, 95% CI: 3.45-4.63, p = 0.002). Mortality: Mortality was higher in the compression group (29.2% vs. 9.1%). Combined Impact: ESRD patients with IVC compression had a lower survival rate (11.9%) than ESRD patients without compression (28.5%) (HR: 5.60, 95% CI: 5.12-6.13, p < 0.001). Conclusions: IVC compression in ADPKD is associated with significantly worse outcomes, including increased ESRD risk, higher mortality, and reduced survival. These findings underscore the importance of early diagnosis and targeted management strategies.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Incomplete Dominance
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Kidney Disease I: Introduction

